AABB |
American Association of Blood Banks |
7-AAD |
7-amino-actinomycin D |
AATB |
American Association of Tissue Banks |
AAV |
adeno-associated virus |
ADA |
amino deaminase |
BSE |
bovine spongiform encephalopathy (mad cow disease) |
CBER |
FDA Center for Biologics Evaluation and Research |
CDC |
The Centers for Disease Control and Prevention |
CDER |
FDA Center for Drug Evaluation and Research |
CDRH |
Center for Devices and Radiological Health |
cfu |
colony-forming unit |
CGMP |
current good manufacturing practice |
CSF |
colony-stimulating factor |
cDNA |
complementary DNA |
DNA |
deoxyribonucleic acid |
ELISA |
enzyme-linked immunosorbent assay |
FBS |
fetal bovine serum |
FACS |
fluorescence-activated cell sorter |
GVHD |
graft versus host disease |
GM-CSF |
granulocytemacrophage colony-stimulating factor |
HSV |
herpes simplex virus |
HRSA |
Health Research Services Administration |
HLA |
human leukocyte antigen |
kb |
kilobase |
NIH |
National Institutes of Health |
NMDR |
National Marrow Donor Registry |
PBPC |
peripheral blood progenitor cell |
PCR |
polymerase chain reaction |
QCQA |
quality controlquality assurance |
RCA |
replication-competent adenovirus |
RCR |
replication-competent retrovirus |
RCV |
replication-competent virus |
rDNA |
recombinant DNA |
RNA |
ribonucleic acid |
SDS-PAGE |
sodium dodecyl sulfate polyacrylamide gel electrophoresis |
TCID50 |
tissue culture infectious dose, 50% |